Cyclosporin galenic forms

Details Cyclosporin galenic forms Cyclosporin galenic forms

1995-06-06

1998-06-02

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514785, 514786, A61K 3813, A61K 4714

Patent

active

057599971

ABSTRACT:
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.

REFERENCES:
patent: 3288824 (1966-11-01), Mahler et al.
patent: 4388307 (1983-06-01), Cavanak
patent: 4390548 (1983-06-01), Yamato et al.
patent: 4990337 (1991-02-01), Kurihara et al.
patent: 5338761 (1994-08-01), Nakajima et al.
patent: 5639724 (1997-06-01), Cavanak
Cavanak, T., et al., Formulation of Dosage Forms, Prog. Allergy, vol. 38, pp. 65-72 (1986).
Reymond, J., et al., In Vitro Model for Ciclosporin Intestinal Absorption in Lipid Vehicles, Pharmaceutical Research, vol. 5, No. 10, pp. 673-676 (1988).
Reymond, J., In Vitro In Vivo Model For The Absorption of Cyclosporin A Dissertation, University of Basel (1986).
Miglyol-Neutral Oils, Dynamit Nobel Chemicals (1975).
Chemical Abstracts, 89: 117874s (Jun. 8, 1978).
Chemical Abstracts, 89: 117875t (Jun. 8, 1978).
Derwent Abstracts, 84-069426/12 (Feb. 19, 1984).
Chemical Abstracts 92:64765k (1980).

Affiliated with

Also associated with

Rating

Cyclosporin galenic forms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclosporin galenic forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin galenic forms will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1459781